Cyanocyproheptadine: role of cholinolytic properties in modulating neuroleptic-induced elevation of striatal homovanillic acid (HVA).
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D002746:Chlorpromazine / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D003533:Cyproheptadine / Q000031:analogs & derivatives* / Q000494:pharmacology; D004347:Drug Interactions; D006719:Homovanillic Acid / Q000378:metabolism*; D008297:Male; D051379:Mice; D009184:Mydriatics; D010095:Oxotremorine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats
D009184:Mydriatics; D010276:Parasympatholytics; D010648:Phenylacetates; D003533:Cyproheptadine; D010095:Oxotremorine; D002746:Chlorpromazine; D006719:Homovanillic Acid